Clinical Trial

Brief Trial of ACT-i for Adults With Chronic Insomnia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2026 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, randomized-controlled trial that assesses the efficacy of a brief Acceptance and Commitment Therapy (ACT-i), compared to an attentional control group, in adults with chronic insomnia. The interventions will be evaluated for their impact on insomnia severity, cognitive function, depression, anxiety, psychological flexibility, and sleep beliefs - measured before treatment, two weeks after and at a three-month follow-up.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05 -> 2026-08-15 2026-08-08
minor Completion pushed: 2026-06 -> 2026-08-30 2026-08-08
Trial Details
NCT Number NCT07048600
Lead Sponsor Babes-Bolyai University
Conditions Chronic Insomnia, Depression - Major Depressive Disorder, Anxiety
Enrollment 76 participants
Start Date 2025-05-23
Primary Completion 2026-08-15 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-07